Back to company

INNOMED INNOVATION MEDICAL ApS: Financial statements 2023

CVR: 25139356

INNOMED INNOVATION MEDICAL ApS (CVR 25139356) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 305,255 and a net result of DKK 97,212 compared with DKK -41,296 the year before. That is an increase of 69.8% compared with the year before. Equity amounted to DKK 278,393. The solvency ratio was 22.9%. The company had 3 employees in the financial year.

Gross Profit
305,255 kr.
Profit/Loss
97,212 kr.
Equity
278,393 kr.
Total Assets
1,214,375 kr.
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-305 t.97 t.278 t.3
2022-180 t.-41 t.181 t.2
2021-240 t.4 t.222 t.2
2020-420 t.158 t.218 t.2
2019-474 t.196 t.520 t.3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

INNOMED INNOVATION MEDICAL ApS: The 2022 annual report is outApr 11, 2023

INNOMED INNOVATION MEDICAL ApS has published its annual report for 2022. Gross profit came to DKK 179,774, and the net result was DKK -41,296.

About INNOMED INNOVATION MEDICAL ApS

INNOMED INNOVATION MEDICAL ApS is a Danish company of the type Anpartsselskab based in Hirtshals, founded in 1999. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jens Kjeldgaard. The company is owned by Jens Kjeldgaard. The company has 3 employees. In 2025, the company reported a gross profit of DKK 248,225 and a net result of DKK 41,979 compared with DKK 64,825 the year before. Equity amounted to DKK 385,198.